Your browser doesn't support javascript.
loading
A novel compound, NK150460, exhibits selective antitumor activity against breast cancer cell lines through activation of aryl hydrocarbon receptor.
Fukasawa, Kazuteru; Kagaya, Shigehide; Maruyama, Sakiko; Kuroiwa, Shunsuke; Masuda, Kuniko; Kameyama, Yoshio; Satoh, Yoshitaka; Akatsu, Yuichi; Tomura, Arihiro; Nishikawa, Kiyohiro; Horie, Shigeo; Ichikawa, Yuh-ichiro.
Afiliação
  • Fukasawa K; Pharmaceutical Research Laboratories, Research and Development Group, Nippon Kayaku Co., Ltd., Kita-ku, Tokyo, Japan. Department of Urology, Graduate School of Medicine, Juntendo University, Bunkyo-ku, Tokyo, Japan. kazuteru.fukasawa@nipponkayaku.co.jp.
  • Kagaya S; Pharmaceutical Research Laboratories, Research and Development Group, Nippon Kayaku Co., Ltd., Kita-ku, Tokyo, Japan.
  • Maruyama S; Pharmaceutical Research Laboratories, Research and Development Group, Nippon Kayaku Co., Ltd., Kita-ku, Tokyo, Japan.
  • Kuroiwa S; Pharmaceutical Research Laboratories, Research and Development Group, Nippon Kayaku Co., Ltd., Kita-ku, Tokyo, Japan.
  • Masuda K; Pharmaceutical Research Laboratories, Research and Development Group, Nippon Kayaku Co., Ltd., Kita-ku, Tokyo, Japan.
  • Kameyama Y; Pharmaceutical Research Laboratories, Research and Development Group, Nippon Kayaku Co., Ltd., Kita-ku, Tokyo, Japan.
  • Satoh Y; Pharmaceutical Research Laboratories, Research and Development Group, Nippon Kayaku Co., Ltd., Kita-ku, Tokyo, Japan.
  • Akatsu Y; Pharmaceutical Research Laboratories, Research and Development Group, Nippon Kayaku Co., Ltd., Kita-ku, Tokyo, Japan.
  • Tomura A; Pharmaceutical Research Laboratories, Research and Development Group, Nippon Kayaku Co., Ltd., Kita-ku, Tokyo, Japan.
  • Nishikawa K; Pharmaceutical Research Laboratories, Research and Development Group, Nippon Kayaku Co., Ltd., Kita-ku, Tokyo, Japan.
  • Horie S; Department of Urology, Graduate School of Medicine, Juntendo University, Bunkyo-ku, Tokyo, Japan.
  • Ichikawa Y; Pharmaceutical Research Laboratories, Research and Development Group, Nippon Kayaku Co., Ltd., Kita-ku, Tokyo, Japan.
Mol Cancer Ther ; 14(2): 343-54, 2015 Feb.
Article em En | MEDLINE | ID: mdl-25522763
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinolinas / Neoplasias da Mama / Receptores de Hidrocarboneto Arílico / Compostos Heterocíclicos com 2 Anéis / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinolinas / Neoplasias da Mama / Receptores de Hidrocarboneto Arílico / Compostos Heterocíclicos com 2 Anéis / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Japão